SAR442257, a CD38/CD28/CD3 trispecific antibody, potentiates CAR T‐cell activity against large B‐cell lymphomaM. R. Green, L. Wang, Chizitara Okwuchi et al.|Hematological Oncology|2023Cited by 2
P1366: SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMAPatrick K. Reville, Michael R. Green, Enyu Dai et al.|HemaSphere|2023Cited by 1
CD8 T-cell dysfunction is linked with CAR T-cell failure and can be mitigated by a non-alpha IL-2 agonist, pegenzileukinPatrick K. Reville, Michael R. Green, Irtiza Sheikh et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1
S259: SAR444245, A NON-ALPHA IL2, RESCUES CHRONIC ANTIGEN- AND CAR-DRIVEN T-CELL DYSFUNCTIONIrtiza Sheikh, Michael R. Green, Ahyun Choi et al.|HemaSphere|2023Cited by 0